SEP-363856 75mg
Sponsors
Otsuka Pharmaceutical Development & Commercialization, Inc.
Conditions
Schizophrenia
Phase 3
A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
CompletedNCT04072354
Start: 2019-09-17End: 2023-09-12Updated: 2026-05-28
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
CompletedNCT04092686
Start: 2019-10-14End: 2023-06-14Updated: 2026-06-18